Potential drug
GUR-701 is a potential drug against hair loss (alopecia).
Topical use
The drug will be for topical use (serum)
Stage
GUR-701 passed pilot clinical trials in 100 patients (Eastern Europe). Preclinical studies completed in Eastern Europe.
Novel molecules
Active Pharmaceutical Ingredient (API) are 3 molecules. These molecules are modified prostaglandins E1, E2 and F2
Unmet medical need
- There are still no effective drugs for hair loss treatment in the world.
- By the age of 35 over 65% of American men experience hair loss*.
- Around 50% of hair loss patients are women*
*Source: The American Hair Loss Association
https://www.americanhairloss.org/men_hair_loss/
Superior efficacy
- Increase in number of hairs is around 25% for 6 months
- No side effect
- Response rate is above 90%
Excellent safety
- GUR-701 has not showed side effects in patients.
Intellectual property
Patents claim submitted worldwide.
Market
Market 2027 = $13 billion